Lucy Xiao-Vance

Lucy Xiao-Vance is an experienced professional in corporate strategy and regulatory affairs, currently serving as the Director of Corporate Strategy at Oxford Biomedica since May 2024. Prior to this, Lucy worked at Boston Consulting Group as a Consultant from February 2020 to June 2022 and held positions in regulatory affairs at Boston Scientific from July 2015 to June 2018. Earlier career experience includes consultancy roles at Brandwood Biomedical, where Lucy was involved in Asia Services from November 2010 to June 2015. Lucy holds an MBA in Business from INSEAD, a Diploma of Project Management from the Institute of Management, and a Bachelor's degree in Biomedical/Mechanical Engineering from the University of Sydney, supplemented by an exchange program in Bioengineering at the University of Pennsylvania.